Skip to content
Search

Latest Stories

RPS concerned over proposals on regulator powers

The Royal Pharmaceutical Society (RPS) has expressed its concern over the government’s new proposals on the reform of regulators that oversee professionals working in health and social care.

While rejecting some of the proposals, the RPS said that it supports many of the proposals which will “provide greater transparency and ensure public safety. Many proposals align with the Cumberledge recommendations which we fully endorse.”


The pharmacy body is worried by new proposals which would label pharmacists with physical or mental health problems as incompetent, and the possible knock-on effect that pharmacists won’t receive the early intervention they need to support them.

“We are also concerned that the label would stigmatise those with genuine health problems,” the RPS said.

“Other proposals to further concentrate powers in the hands of regulators are alarming. Under these proposals, the final say about whether an outcome should be changed because it is unsafe would sit with the regulator, rather than with the courts as it does now,” it noted.

This new model would make the regulator not only investigator, prosecutor, and judge, but also appeal court. This concentration of powers could mean that mistakes are not spotted or challenged.

Expressing its concern over the proposals, the RPS said, “The Professional Standards Authority must continue to provide an alternative appeals system to ensure the system has enough checks and balances to ensure registrants are treated fairly.

“We support the proposals for increased consistency across regulators in relation to education and training. We believe that regulation and annotation of the register should be proportionate with a focus on ensuring public safety.”

“We believe that post registration education regulation should focus on outcomes, so that registrants have choice and flexibility in how they meet the standards.”

This standards include being able to pick and choose short courses or modules to suit, or mix academic programmes with private provision or collate a portfolio of vocational experience. A move towards the accreditation and approval of formal courses may limit this, the RPS said.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less